1. Volume 66, Issue 4, Pages 1527-1534 (October 2004)
Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease 
Allan M. Evans, Randall J. Faull, Roger L. Nation, Shilpanjali Prasad, Tony Elias, Stephanie E. Reuter, Gianfranco Fornasini 
Kidney International 
Volume 66, Issue 4, Pages (October 2004)
DOI: /j x
Copyright © 2004 International Society of Nephrology Terms and Conditions

2. Figure 1
Mean ± SEM plasma concentrations of L-carnitine (upper panel), acetyl-L-carnitine (middle panel), and total L-carnitine (lower panel) in patients with end-stage renal diseasen (ESRD) during the first 12 months of hemodialysis treatment.*Compared with baseline, P < 0.05.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

3. Figure 2
Plasma concentrations of L-carnitine (upper panel), acetyl-L-carnitine (middle panel), and total L-carnitine (lower panel) from longitudinal (▪) and single-session (□) patients as a function of dialysis age.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

4. Figure 3
The impact of hemodialysis on the relative composition of the plasma total L-carnitine pool.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions

5. Figure 4
Skeletal muscle concentrations of L-carnitine (upper panel), acetyl-L-carnitine (middle panel), and total L-carnitine (lower panel) from longitudinal (▪) and single-session (□) patients as a function of dialysis age.
Kidney International  , DOI: ( /j x)
Copyright © 2004 International Society of Nephrology Terms and Conditions